Global Acute Sinusitis Market, By Treatment (Diagnosis, Medication), End User (Hospitals, Clinics, Research Institutes and ENTC Specialists), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Global acute sinusitis market is expected to gain market growth in coming years based on the market size, increasing demand among the population throughout and technical advancements and increasing investments in the area. The market is growing with the CAGR of 7% in the above-mentioned research forecast period.
Acute sinusitis is short-term inflammation of mucous membranes of the paranasal sinuses that surround the nasal cavity. It’s a prevalent disease with easily identifiable symptoms, including nasal discharge; sneezing, nasal obstruction, facial pressure, tenderness and swelling over the affected sinus, headache, cough, fever, chills, hyposmia (i.e. reduced ability to smell). Diagnosis can be made by standard tests and procedures, including endoscopy, CT scan, X- ray, allergy skin test and nasopharyngeal culture. Treatment can be done by medication and self-care.
As acute sinusitis is prevalent among the population worldwide, manufacturers and the government are working together to address the situation and provide better solutions, investments in the technological advancements by both government and private sectors is increasing the probability for increment in market. Moreover, increasing preference for over-the-counter drugs/ medications, including nasal corticosteroids and nasal sprays, is anticipated to fuel market growth in years to come.
One of the biggest issues being faced by developing countries is the lack of awareness about acute sinusitis, which can have negative impacts on market growth in such countries. Moreover, the pharmaceutical companies face another challenge: the longer approval time for drugs by FDA and lengthy procedures for clinical trials.
This global acute sinusitis market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Acute Sinusitis Market Scope and market size
Global acute sinusitis market is segmented into treatment, end user. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of treatment, the acute sinusitis market is segmented into diagnosis and medication. Further, diagnosis is segmented into laboratory test, nasal endoscopy, allergy test and imaging test. Imaging test can be sub-segmented into magnetic resonance imaging (MRI) and computer tomography. Being a non-invasive way to view structures inside the body and inflammation, magnetic resonance imaging (MRI) is boosting the segment growth further. Moreover, medication can be segmented into allergy shots, OTC pain relievers, antibiotics, decongestant, nasal corticosteroids and saline nasal sprays. Being very effective in reducing inflammation and its widely accepted uses to relieve symptoms such as sinus congestion, nasal swelling and mucus production, nasal corticosteroids is expected to hold major market share.
- On the basis of end user, acute sinusitis market can be segmented into hospitals and clinics, research institutes and ENTC specialists. As a huge number of patients visit hospitals for sinusitis treatment, hospitals segment is expected to hold a major market share.
Global Acute Sinusitis Market Country Level Analysis
Acute sinusitis market is analyzed and market size, volume information is provided by country, treatment, and end user as referenced above.
Countries covered in the acute sinusitis market include U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.
Technical progression in diagnostic services, increased expenditure and easy access to healthcare facilities has increased the market growth in North America. Market growth in the U.S. is being boosted by increased incidences of chronic diseases. A large population in America is affected by acute sinusitis according to CDC. In the Asia-Pacific, India holds a major population for chronic respiratory diseases, according to Institute for Health Metrics and Evaluation. Moreover, growing number of patients suffering from sinusitis, easy treatment availability and increasing demand of cost-effective treatments are driving the growth of market in these regions.
The country section of the acute sinusitis market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Global Acute Sinusitis Market Patient epidemiology analysis
Acute sinusitis market is mainly seen in immunocompromised patients; hence the demographics match with those of underlying immunosuppressing conditions. Although Acute Sinusitis is fairly common along a large portion of the globe and is transported through airborne exposure, under developed and developing countries have comparatively larger number of patients for the disease mainly because of the lack of awareness and partially because of challenging accessibility to affordable healthcare for financially challenged population.
Competitive landscape and Global Acute Sinusitis Market Share Analysis
While studying the market for any disease, details about potential competitors and major players plays an important role. These details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. These details help understand trends and scope of improvements.
For the manufacturing of treatment products (i.e. antibiotics) for sinusitis in the acute sinusitis market, some of the key market players include Novartis AG, AstraZeneca, Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Abbott., Sanofi, Bayer AG, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Amgen Inc. and Bionorica SE among other domestic and global players. Acute sinusitis market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.